Table 3 Univariate and multivariate analysis for exercise intolerance.
Variables | Univariate analysis | Multivariate analysis | ||||
---|---|---|---|---|---|---|
OR | 95% CI | P value | OR | 95% CI | P value | |
CHA2DS2-VASc score* | 1.60 | 1.41–1.80 | <0.0001 | 1.54 | 1.31–1.81 | <0.0001 |
BMI (kg/m2) | 1.06 | 1.01–1.12 | 0.025 | 1.05 | 0.99–1.12 | 0.115 |
Smoking | 0.73 | 0.50–1.08 | 0.119 | 1.34 | 0.83–2.16 | 0.229 |
Chronic kidney disease | 1.96 | 1.15–3.32 | 0.013 | 0.97 | 0.50–1.89 | 0.924 |
Persistent AF** | 1.69 | 1.13–2.53 | 0.011 | 1.25 | 0.74–2.13 | 0.407 |
Permanent AF** | 0.61 | 0.14–2.59 | 0.499 | 0.79 | 0.09–6.76 | 0.832 |
QTc interval (ms) | 1.01 | 1.00–1.02 | 0.001 | 1.01 | 1.00–1.02 | 0.026 |
LVEF (%) | 1.01 | 0.98–1.04 | 0.542 | 1.01 | 0.97–1.05 | 0.659 |
E/E’ | 1.10 | 1.05–1.15 | <0.0001 | 1.01 | 0.96–1.07 | 0.656 |
LAVI (ml/m2) | 1.02 | 1.02–1.03 | <0.0001 | 1.02 | 1.01–1.03 | 0.001 |
Resting DBP (mmHg) | 0.97 | 0.96–0.99 | 0.003 | 0.98 | 0.96–1.00 | 0.054 |
Resting HR (bpm) | 1.01 | 0.99–1.02 | 0.206 | 1.01 | 0.99–1.02 | 0.259 |
Use of beta-blocker | 1.31 | 0.91–1.90 | 0.145 | 1.14 | 0.73–1.78 | 0.572 |